' ,ildrenls How of Philadelphia, PA EBV has been sporadically described as a cause of infectious mnonucleosis (IM) following transfusion of blood (TOB) but systematic studies t o establish the risk of EBV infection (in£), both silent and overt, from ' RJB have not been perfomd. We undertook a pilot study t o ascertain whether children undergoing open heart surgery (OHS) requiring TOB developed 5 V inf. 44 children, 3 ms-15 yrs (rredian 5 yrs), were enrolled and tested for EBV-specific a n t i w i e s a t entry and 1,4,12,26, and 52-78 wks after surgery. 29(66%)/44 were seroneg; 3/29 (10%) died and 5(17%) have been lost t o follow up. These seroneg children received 1-5 TOB (man 3.65 units): 89% of the 106 units were seropos and each seroneg child was exposed t o a t least 1 seropos unit. Of the 21 seroneg ( a l l followed >6 ms) , 17 (81%) remained susceptible and 409%) seroconverted, including a 15 y/o who developed I M and 3 children 6-18 m s old with asymptomtic in£. Two asymptmtic inf probably occurred 2-6 m s after surgery and the other >6 m s postoperatively. W e conclude that children undergoing OHS are a t risk of acquiring EEj V from ' RJB as they are likely (a)to be susceptible and (b)to receive seropos blood (containing EBV-infected lymphocytes). Additionally, the detection of 5 V in£ in 4 children following OHS suggests a need for larger, controlled studies t o determine whether the source of such postoperative infections i s TOB.
THE EFFECT OF BETAMETHASONE ON THE CHEMOTACTIC
Antenatal maternal steroid administration has been widelv used to accelerate fetal lung maturation. There is evidence that this therapy may be associated with an increased risk of infection in the neonate. Inhibition of multiple aspects of neutrophil (PMN) function by glucocorticoids has been widely documented in adults and children. Because the host defense system of the neonate is less than fully competent, further compromise of existing PMN function may be of major importance. We performed an in vitro study to determine the effect of betamethasone on the random migration (chemokinesis) and directed migration (chemotaxis) on neonatal PMN. A separated cell micropore filter assay was used to study the effect of betamethasone on PMN's obtained from cord blood of healthy term neonates. The addition of therapeutic concentrations of betamethasone (1.0 ~1gm/100 ml) resulted in a significant inhibition in PMN chemokinesis and chemotaxis. CHEMOKINESIS CHEMOTAXIS Control Betamethasone Control Betamethasone Mean Migration (!&I) 54.9f1.60 43.7f13.8 86.8f15.0 56.9f16.8 Inhibition (%) 20.2f8.7 29.4f13.5 n = 15 p <0.001 p <0.001 Betamethasone inhibition of PMN motility, if present in vivo may lead to a clinically significant susceptability to perinatal bacterial infection.
COXSACKIEVIRllSES GROUP B ANTIBODIES I N THE VENTRICII-LAR CEREBROSPINAL FLUID OF INFANTS WITH SEVERE ANA-TOYICAL DEFECTS I N THE CENTRAL NERVOUS SYSTEV.
Charles J. Gauntt, Richard J. Gudvanqen, Yves W. Brans and A r t h u r E. M a r l i n . The Univ o f TX H e a l t h Science C t r a t San Antonio, Depts o f P e d i a t r i c s and Microbioloqy, San Antonio, TX.
Coxsackieviruses group B (CVB) i F e u b i q u i t o u s v i r u s e s which r a r e l y may be i n v o l v e d i n congenital diseases and a r e known t o cause c e n t r a l nervous system i n f e c t i o n s . W e s e t o u t t o determine whether t h e CVB might be associated w i t h severe congenital anatom i c a l d e f e c t s i n t h e c e n t r a l nervous system (CNS), m a i n l y congeni t a l hydrocephalus, i n i n f a n t s . V e n t r i c u l a r cerebrospinal f l u i d s from 4 o f 28 newborn i n f a n t s p r e s e n t i n g w i t h severe problems o f t h e CNS contained n e u t r a l i z i n g a n t i b o d y t o a t l e a s t one serotype o f t h e CVB. Two o f t h e 4 i n f a n t s w i t h anti-CVB a n t i b o d y i n t h e v e n t r i c u l a r f l u i d d i d n o t have a d e t e c t a b l e l e v e l o f t h e same a n t i b o d y ( i e s ) i n t h e i r serum. Hydranencephaly was diagnosed i n 2 o f these same 4 i n f a n t s . The v e n t r i c u l a r f l u i d o f one o f t h e i nf a n t s had IgM n e u t r a l i z i n g a n t i b o d y d i r e c t e d a g a i n s t coxsackiev i r u s 86. Of 11 m o t h e r l i n f a n t p a i r s which had n e u t r a l i z i n g a n t ibody t o CVB i n both sera, almost h a l f had a n t i b o d i e s d i r e c t e d a g a i n s t more than one serotype. N e u t r a l i z i n g a n t i b o d i e s t o a l l 6 serotypes except c o x s a c k i e v i r u s 65 were found. I s o l a t i o n o f a v i r u s from t h e v e n t r i c u l a r cerebrospinal f l u i d s was unsuccessful. These data suggest t h e p o s s i b i l i t y o f an a s s o c i a t i o n between cong e n i t a l i n f e c t i o n s w i t h t h e CVB and severe CNS defects. Preliminary studies have d-strated the ability of this isolate t o produce grmlomatous lesions in mice and a cell-mediated irmnole response in guinea pigs. Work i s i n progress t o fixther define the characteristics and pathogenicity of t h i s organism. Most children with GABHS pharyngitis are treated with oral penicillin given either 3 or 4 times a day. In order to determine if a twice daily regimen would be as effective, 99 children with acute pharyngitis and a positive throat culture for GABHS were randomized to receive either 250 mg of penV t.i.d. or 250 mg of penV b.i.d. for 10 days. Compliance was checked by analyzing urine specimens for antimicrobial activity. Two weeks after completing therapy, patients returned for a follow-up throat culture. Acute and convalescent streptococcal serology were obtained on all patients. There was no difference between the two treatment groups with respect to age, sex, race, duration of illness prior to therapy, clinical findings, compliance, or percentage of children with an antibody rise. Nine of the 50 (18%) patients who received the t.i.d. regimen and 14 of the 49 (29%) patients who received the b.i.d. regimen had the same strain of GABHS (as determined by M-and T-typing) isolated from their follow-up as from their initial throat culture and were considered penicillin treatment failures (~>0.2).
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THE EFFECTIVENESS OF TWICE DAILY PENICILLIN V (PENV) IN THE TREATMENT OF GROUP
One of the 9 (22%) treatment failures in the t.i.d. group and 5 of the 14 (36%) treatment failures in the b.i.d. group were symptomatic at the time of their follow-up visits. Oral penV given twice a day appears as effective in the treatment of GABHS pharyngitis as penV given three times a day and is more convenient especially for children attending school. These data indicate that in general, the higher the VZ antibody titer the better the protection against varicella. Vaccinees with a breakthrough illness, however, have partial immunity that appears to protect them from severe disease.
DETERMINANTS OF IMMUNITY
